Medpace Holdings, Inc.·4

Jun 1, 4:27 PM ET

EWALD STEPHEN P 4

Research Summary

AI-generated summary

Updated

Medpace (MEDP) GC Stephen P. Ewald Exercises Options, Sells Shares

What Happened

  • Stephen P. Ewald, General Counsel & Corporate Secretary of Medpace Holdings (MEDP), exercised stock options and sold the resulting 16,349 shares on May 28, 2026.
  • He paid $138.87 per share to exercise (cost ≈ $2,270,386) and sold the shares at $450.00 each (proceeds ≈ $7,357,050), for an approximate pre-tax net of $5,086,664.
  • This is a sale following option exercise (a cashless-style transaction where shares were immediately sold), which is commonly done to cover the exercise cost, taxes, or diversify holdings.

Key Details

  • Transaction date: 2026-05-28; Form 4 filed: 2026-06-01 (filed timely).
  • Exercise: 16,349 shares at $138.87/share (acquired).
  • Sale: 16,349 shares at $450.00/share (disposed) — proceeds ≈ $7,357,050.
  • A related derivative line shows the option conversion/disposition (reported at $0), reflecting the exercise/settlement of the option.
  • Shares owned after the transaction: not specified in the provided filing detail.
  • Footnotes: F1 — transactions executed via a limit order placed during an open window; F2 — the option vested in full on February 15, 2026.

Context

  • For retail investors: this is an insider exercising vested options then selling the shares the same day, a routine action that raises cash rather than a clear directional bet on the stock.
  • Such transactions are common among executives to cover exercise costs and tax liabilities; they do not necessarily indicate a change in confidence in the company.